Multi-Regional Clinical Trials Center

  • Read more: Tomorrow: Post-Trial Responsibilities Conference

    Tomorrow: Post-Trial Responsibilities Conference

    Post-Trial Responsibilities: Ethics and Implementation Thursday, September 18, 2014 7:30 AM – 5:30 PM Wasserstein Hall, Milstein East AB, Harvard Law School, 1585 Massachusetts Ave. The conference is free and open to the public, but due to limited seating, registration is required to attend. Please register here. The term “post-trial access” is used broadly to connote a wide range…

  • Read more: Post-Trial Access and Responsibilities (and Upcoming Conference, Sept. 18 at HLS)

    Post-Trial Access and Responsibilities (and Upcoming Conference, Sept. 18 at HLS)

    By Zachary Shapiro Post-Trial Access (PTA) is emerging as an important topic in the design of ethical clinical trial protocols. PTA refers to the provision of study drug to the participants in a successful clinical trial (and maybe others) during the crucial period after a clinical trial phase is over, but before the drug is…

  • Read more: 9/18/14: Post-Trial Responsibilities Conference

    9/18/14: Post-Trial Responsibilities Conference

    Post-Trial Responsibilities: Ethics and Implementation Thursday, September 18, 2014 7:30 AM – 5:30 PM Wasserstein Hall, Milstein East AB, Harvard Law School, 1585 Massachusetts Ave. The conference is free and open to the public, but due to limited seating, registration is required to attend. Please register here. The term “post-trial access” is used broadly to…